Mesenchymal stem cell-based HSP70 promoter-driven VEGFA induction by resveratrol promotes angiogenesis in a mouse model

Cell Stress and Chaperones

Volumn 20, Issue 4, 2015, Pages 643-652

  Chen, Young Bin ^a   Lan, Ying Wei ^b   Hung, Tsai Hsien ^b   Chen, Lih Geeng ^d   Choo, Kong Bung ^e   Cheng, Winston T K ^f   Lee, Hsuan Shu ^a,g   Chong, Kowit Yu ^b,c  

^a NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^c CHANG GUNG MEMORIAL HOSPITAL   (Taiwan)

^d NATIONAL CHIAYI UNIVERSITY   (Taiwan)

^e UNIVERSITI TUNKU ABDUL RAHMAN   (Malaysia)

^f TUNGHAI UNIVERSITY   (Taiwan)

^g NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

Angiogenesis; Hsp70 promoter; Mouse model; Resveratrol; Stem cell based gene therapy; VEGFA

Indexed keywords

CELL MARKER; HEAT SHOCK PROTEIN 70; RESVERATROL; UNCLASSIFIED DRUG; VEGFA PROTEIN; STILBENE DERIVATIVE; VASCULOTROPIN A;

ANGIOGENESIS; ANIMAL CELL; ARTICLE; BIOLOGICAL FUNCTIONS; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL REGENERATION; COCULTURE; CONTROLLED STUDY; CYTOTOXICITY; EX VIVO STUDY; FEMALE; HEART PROTECTION; HUMAN; HUMAN CELL; IN VIVO STUDY; ISCHEMIA; MALE; MESENCHYMAL STEM CELL TRANSPLANTATION; MOUSE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; STEM CELL GENE THERAPY; TISSUE INJURY; UMBILICAL VEIN ENDOTHELIAL CELL; VASCULAR RING; ANIMAL; AORTA; BONE MARROW CELL; C57BL MOUSE; CELL CULTURE; CELL CULTURE TECHNIQUE; CELL SURVIVAL; CYTOLOGY; DISEASE MODEL; DRUG EFFECTS; GENETICS; IN VITRO STUDY; ISOMERISM; MESENCHYMAL STROMA CELL; METABOLISM; PATHOLOGY;

RICE STRIPE VIRUS;

ANIMALS; AORTA; BONE MARROW CELLS; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; CELLS, CULTURED; COCULTURE TECHNIQUES; DISEASE MODELS, ANIMAL; HSP70 HEAT-SHOCK PROTEINS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; IN VITRO TECHNIQUES; ISCHEMIA; ISOMERISM; MESENCHYMAL STEM CELL TRANSPLANTATION; MESENCHYMAL STROMAL CELLS; MICE; MICE, INBRED C57BL; NEOVASCULARIZATION, PHYSIOLOGIC; STILBENES; VASCULAR ENDOTHELIAL GROWTH FACTOR A;

EID: 84930865264     PISSN: 13558145     EISSN: 14661268     Source Type: Journal    
DOI: 10.1007/s12192-015-0588-x     Document Type: Article

References (48)

1. Advani SH (2010) Targeting mTOR pathway: A new concept in cancer therapy. Indian J Med Pediatr Oncol 31:132–136
2. Ait-Aissa S, Porcher J, Arrigo A, Lambre C (2000) Activation of the hsp70 promoter by environmental inorganic and organic chemicals: relationships with cytotoxicity and lipophilicity. Toxicology 145:147–157
3. Baker M, Robinson SD, Lechertier T, Barber PR, Tavora B, D'Amico G, Jones DT, Vojnovic B, Hodivala-Dilke K (2012) Use of the mouse aortic ring assay to study angiogenesis. Nat Protoc 7:89–104. doi:10.1038/nprot.2011.435
4. Baron-Menguy C, Bocquet A, Guihot AL, Chappard D, Amiot MJ, Andriantsitohaina R, Loufrani L, Henrion D (2007) Effects of red wine polyphenols on postischemic neovascularization model in rats: low doses are proangiogenic, high doses anti-angiogenic. FASEB J 21:3511–3521. doi:10.1096/fj.06-7782com
5. Belleri M, Ribatti D, Savio M, Stivala LA, Forti L, Tanghetti E, Alessi P, Coltrini D, Bugatti A, Mitola S, Nicoli S, Vannini V, Presta M (2008) alphavbeta3 Integrin-dependent antiangiogenic activity of resveratrol stereoisomers. Mol Cancer Ther 7:3761–3770. doi:10.1158/1535-7163.MCT-07-2351
6. Chan AW, Chong KY, Martinovich C, Simerly C, Schatten G (2001) Transgenic monkeys produced by retroviral gene transfer into mature oocytes. Science 291:309–312. doi:10.1126/science.291.5502.309
7. Chen PL, Easton AS (2011) Anti-angiogenic effects of resveratrol on cerebral angiogenesis. Curr Neurovasc Res 8:14–24
8. Chong KY, Lai CC, Su CY (2013) Inducible and constitutive HSP70s confer synergistic resistance against metabolic challenges. Biochem Biophys Res Commun 430:774–779. doi:10.1016/j.bbrc.2012.11.072
9. Chong KY, Hsu CJ, Hung TH, Hu HS, Wang TH, Wang CH, Chen CM, Choo KB, Lai HC, Tseng CP (2015) Wnt pathway activation and ABCB1 expression account for attenuation of proteasome Inhibitor-mediated apoptosis in multidrug-resistant cancer cells. Cancer Biol Ther 16:149–159. doi:10.4161/15384047.2014.987093
10. Chun JL, O'Brien R, Song MH, Wondrasch BF, Berry SE (2013) Injection of vessel-derived stem cells prevents dilated cardiomyopathy and promotes angiogenesis and endogenous cardiac stem cell proliferation in mdx/utrn-/- but not aged mdx mouse models for duchenne muscular dystrophy. Stem Cells Transl Med 2:68–80. doi:10.5966/sctm. 2012-0107
11. Fierro FA, Kalomoiris S, Sondergaard CS, Nolta JA (2011) Effects on proliferation and differentiation of multipotent bone marrow stromal cells engineered to express growth factors for combined cell and gene therapy. Stem Cells 29:1727–1737. doi:10.1002/stem.720
12. Galbraith R (1999) Heme oxygenase: who needs it? Proc Soc Exp Biol Med 222:299–305
13. Gawad A, Ptak-Belowska A, Brzozowski T, Pawlik WW (2009) Monocytes and vascular endothelial cells apoptosis. Role of p-HSP27. J Physiol Pharmacol 60:55–61
14. Gerhardt H (2008) VEGF and endothelial guidance in angiogenic sprouting. Organogenesis 4:241–246
15. Guertin DA, Sabatini DM (2007) Defining the role of mTOR in cancer. Cancer Cell 12:9–22
16. Huang TT, Lai HC, Chen YB, Chen LG, Wu YH, Ko YF, Lu CC, Chang CJ, Wu CY, Martel J, Ojcius DM, Chong KY, Young JD (2014) cis-Resveratrol produces anti-inflammatory effects by inhibiting canonical and non-canonical inflammasomes in macrophages. Innate Immun 20:735–750. doi:10.1177/1753425913507096
17. Hung TH, Chen CM, Tseng CP, Shen CJ, Wang HL, Choo KB, Chong KY (2014a) FZD1 activates protein kinase C delta-mediated drug-resistance in multidrug-resistant MES-SA/Dx5 cancer cells. Int J Biochem Cell Biol 53:55–65. doi:10.1016/j.biocel.2014.04.011
18. Hung TH, Hsu SC, Cheng CY, Choo KB, Tseng CP, Chen TC, Lan YW, Huang TT, Lai HC, Chen CM, Chong KY (2014b) Wnt5A regulates ABCB1 expression in multidrug-resistant cancer cells through activation of the non-canonical PKA/beta-catenin pathway. Oncotarget 5:12273–12290
19. Iizuka T, Ishii Y, Itoh K, Kiwamoto T, Kimura T, Matsuno Y, Morishima Y, HegabAE HS, Nomura A, Sakamoto T, Shimura M, Yoshida A, Yamamoto M, Sekizawa K (2005) Nrf2-deficient mice are highly susceptible to cigarette smoke-induced emphysema. Genes Cells 10:1113–1125. doi:10.1111/j.1365-2443.2005.00905.x
20. Isomoto H, Ohtsuru A, Braiden V, Iwamatsu M, Miki F, Kawashita Y, Mizuta Y, Kaneda Y, Kohno S, Yamashita S (2006) Heat-directed suicide gene therapy mediated by heat shock protein promoter for gastric cancer. Oncol Rep 15:629–635
21. Janeczek Portalska K, Leferink A, Groen N, Fernandes H, Moroni L, van Blitterswijk C, de Boer J (2012) Endothelial differentiation of mesenchymal stromal cells. PLoS One 7:e46842. doi:10.1371/journal.pone.0046842
22. Jurivich DA, Sistonen L, Sarge KD, Morimoto RI (1994) Arachidonate is a potent modulator of human heat shock gene transcription. Proc Natl Acad Sci U S A 91:2280–2284
23. Kaga S, Zhan L, Matsumoto M, Maulik N (2005) Resveratrol enhances neovascularization in the infarcted rat myocardium through the induction of thioredoxin-1, heme oxygenase-1 and vascular endothelial growth factor. J Mol Cell Cardiol 39:813–822. doi:10.1016/j.yjmcc.2005.08.003
24. Kalil RA, Salles FB, Giusti II, Rodrigues CG, Han SW, Sant'Anna RT, Ludwig E, Grossman G, Prates PR, Sant'anna JR, Teixeira Filho GF, Nardi NB, Nesralla IA (2010) VEGF gene therapy for angiogenesis in refractory angina: phase I/II clinical trial. Rev Bras Cir Cardiovasc 25:311–321
25. Kimura H, Weisz A, Kurashima Y, Hashimoto K, Ogura T, D'Acquisto F, Addeo R, Makuuchi M, Esumi H (2000) Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: control of hypoxia-inducible factor-1 activity by nitric oxide. Blood 95:189–197
26. Lambrechts D, Devriendt K, Driscoll DA, Goldmuntz E, Gewillig M, Vlietinck R, Collen D, Carmeliet P (2005) Low expression VEGF haplotype increases the risk for tetralogy of Fallot: a family based association study. J Med Genet 42:519–522. doi:10.1136/jmg.2004.026443
27. Leblond AL, Naud P, Forest V, Gourden C, Sagan C, Romefort B, Mathieu E, Delorme B, Collin C, Pagès JC, Sensebé L, Pitard B, Lemarchand P (2009) Developing cell therapy techniques for respiratory disease: intratracheal delivery of genetically engineered stem cells in a murine model of airway injury. Hum Gene Ther 20:1329–1343. doi:10.1089/hum.2009.035
28. Lee EJ, Park HW, Jeon HJ, Kim HS, Chang MS (2013) Potentiated therapeutic angiogenesis by primed human mesenchymal stem cells in a mouse model of hindlimb ischemia. Regen Med 8:283–293. doi:10.2217/rme.13.17
29. Leeper NJ, Hunter AL, Cooke JP (2010) Stem cell therapy for vascular regeneration: adult, embryonic, and induced pluripotent stem cells. Circulation 122:517–526. doi:10.1161/CIRCULATIONAHA.109.881441
30. Liao Y, Feng J, Yi Q, Cui H, He L, Tang L (2013) A siRNA system based on HSP70 promoter results in controllable and powerful gene silencing by heat-induction. Biotechnol Prog 29:1289–1297. doi:10.1002/btpr.1781
31. Lin H, Shabbir A, Molnar M, Yang J, Marion S, Canty JM Jr, Lee T (2008) Adenoviral expression of vascular endothelial growth factor splice variants differentially regulate bone marrow-derived mesenchymal stem cells. J Cell Physiol 216:458–468. doi:10.1002/jcp.21414
32. Liu J, Razani B, Tang S, Terman BI, Ware JA, Lisanti MP (1999) Angiogenesis activators and inhibitors differentially regulate caveolin-1 expression and caveolae formation in vascular endothelial cells. Angiogenesis inhibitors block vascular endothelial growth factor-induced down-regulation of caveolin-1. J Biol Chem 274:15781–15785
33. Luczak K, Balcerczyk A, Soszynski M, Bartosz G (2004) Low concentration of oxidant and nitric oxide donors stimulate proliferation of human endothelial cells in vitro. Cell Biol Int 28:483–486. doi:10.1016/j.cellbi.2004.03.004
34. Moon WS, Rhyu KH, Kang MJ, Lee DG, Yu HC, Yeum JH, Koh GY, Tarnawski AS (2003) Overexpression of VEGF and angiopoietin 2: a key to high vascularity of hepatocellular carcinoma? Mod Pathol 16:552–557. doi:10.1097/01.MP.0000071841.17900.69
35. Moon HH, Joo MK, Mok H, Lee M, Hwang KC, Kim SW, Jeong JH, Choi D, Kim SH (2014) MSC-based VEGF gene therapy in rat myocardial infarction model using facial amphipathic bile acid-conjugated polyethyleneimine. Biomaterials 35:1744–1754. doi:10.1016/j.biomaterials.2013.11.019
36. Pagidipati NJ, Gaziano TA (2013) Estimating deaths from cardiovascular disease: a review of global methodologies of mortality measurement. Circulation 127:749–756. doi:10.1161/CIRCULATIONAHA.112.128413
37. Porcu P, Emanueli C, Kapatsoris M, Chao J, Chao L, Madeddu P (2002) Reversal of angiogenic growth factor upregulation by revascularization of lower limb ischemia. Circulation 105:67–72
38. Putics A, Vegh EM, Csermely P, Soti C (2008) Resveratrol induces the heat-shock response and protects human cells from severe heat stress. Antioxid Redox Signal 10:65–75. doi:10.1089/ars.2007.1866
39. Reinders ME, Rabelink TJ, Briscoe DM (2006) Angiogenesis and endothelial cell repair in renal disease and allograft rejection. J Am Soc Nephrol 17:932–942. doi:10.1681/ASN.2005121250
40. Risau W (1997) Mechanisms of angiogenesis. Nature 386:671–674. doi:10.1038/386671a0
41. Rissanen TT, Rutanen J, Yla-Herttuala S (2004) Gene transfer for therapeutic vascular growth in myocardial and peripheral ischemia. Adv Genet 52:117–164. doi:10.1016/S0065-2660(04)52004-7
42. Shakibaei M, Harikumar KB, Aggarwal BB (2009) Resveratrol addiction: to die or not to die. Mol Nutr Food Res 53:115–128. doi:10.1002/mnfr.200800148
43. Spilsbury K, Garrett KL, Shen WY, Constable IJ, Rakoczy PE (2000) Overexpression of vascular endothelial growth factor (VEGF) in the retinal pigment epithelium leads to the development of choroidal neovascularization. Am J Pathol 157:135–144. doi:10.1016/S0002-9440(10)64525-7
44. Ushio-Fukai M, Urao N (2009) Novel role of NADPH oxidase in angiogenesis and stem/progenitor cell function. Antioxid Redox Signal 11:2517–2533. doi:10.1089/ARS.2009.2582
45. Wang Y, Kilic E, Kilic U, Weber B, Bassetti CL, Marti HH, Hermann DM (2005) VEGF overexpression induces post-ischaemic neuroprotection, but facilitates haemodynamic steal phenomena. Brain 128:52–63
46. Wray LS, Hu X, Gallego J, Georgakoudi I, Omenetto FG, Schmidt D, Kaplan DL (2011) Effect of processing on silk-based biomaterials: reproducibility and biocompatibility. J Biomed Mater Res B Appl Biomater 99:89–101. doi:10.1002/jbm.b.31875
47. Xiao Z, Kong Y, Yang S, Li M, Wen J, Li L (2007) Upregulation of Flk-1 by bFGF via the ERK pathway is essential for VEGF-mediated promotion of neural stem cell proliferation. Cell Res 17:73–79. doi:10.1038/sj.cr.7310126
48. Zhang M, Zhang BH, Chen L, An W (2002) Overexpression of heme oxygenase-1 protects smooth muscle cells against oxidative injury and inhibits cell proliferation. Cell Res 12:123–132. doi:10.1038/sj.cr.7290118